MedTrace Logo

Japan FFRangio Clinical Outcomes Study

NCT05648396 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2022-12-13

No results posted yet for this study

Summary

This study aims to collect data on clinical outcomes of real world patients undergoing FFRangio guided treatment for coronary artery disease in Japan and Israel through a retrospective multicentre registry.

Conditions

Interventions

OTHER

FFRangio

Assessing the physiologic significance of an intermediate coronary lesion/lesions using FFRangio - a non invasive method to calculate the fractional flow reserve (FFR) of the assessed lesion.

Sponsors & Collaborators

  • Gifu Heart Center

    collaborator OTHER

  • Fukuoka Sanno Hospital

    collaborator UNKNOWN

  • Saga-ken Medical Center Koseikan

    collaborator UNKNOWN

  • Sakakibara Heart Institute

    collaborator OTHER

  • Fukuyama Cardiovascular Hospital

    collaborator UNKNOWN

  • Ichinomiya-Nishi Hospital

    collaborator UNKNOWN

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Guy Witberg, MD, MPH · Rabin Medical Centre

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-07
Primary Completion
2024-12-31
Completion
2027-12-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05648396 on ClinicalTrials.gov